DK82784A - Fremgangsmaade til fremstilling af lyofiliserede, adsorberede polyvalente vacciner - Google Patents

Fremgangsmaade til fremstilling af lyofiliserede, adsorberede polyvalente vacciner Download PDF

Info

Publication number
DK82784A
DK82784A DK82784A DK82784A DK82784A DK 82784 A DK82784 A DK 82784A DK 82784 A DK82784 A DK 82784A DK 82784 A DK82784 A DK 82784A DK 82784 A DK82784 A DK 82784A
Authority
DK
Denmark
Prior art keywords
adsorped
lyophilized
procedure
preparation
polyvalent vaccines
Prior art date
Application number
DK82784A
Other languages
Danish (da)
English (en)
Other versions
DK82784D0 (da
Inventor
Zoltan Csizer
Karoly Sikos
Laszlo Bacskai
Istvan Joo
Eleonora Niedermayer
Lajos Rethy
Jozsef Zsidai
Original Assignee
Human Oltoanyagtermelo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Oltoanyagtermelo filed Critical Human Oltoanyagtermelo
Publication of DK82784D0 publication Critical patent/DK82784D0/da
Publication of DK82784A publication Critical patent/DK82784A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK82784A 1983-02-22 1984-02-21 Fremgangsmaade til fremstilling af lyofiliserede, adsorberede polyvalente vacciner DK82784A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU83609A HU188847B (en) 1983-02-22 1983-02-22 Process for producing liophylized combined vaccines

Publications (2)

Publication Number Publication Date
DK82784D0 DK82784D0 (da) 1984-02-21
DK82784A true DK82784A (da) 1984-08-23

Family

ID=10950430

Family Applications (1)

Application Number Title Priority Date Filing Date
DK82784A DK82784A (da) 1983-02-22 1984-02-21 Fremgangsmaade til fremstilling af lyofiliserede, adsorberede polyvalente vacciner

Country Status (18)

Country Link
US (1) US4578270A (it)
JP (1) JPS59196821A (it)
BE (1) BE898955A (it)
CA (1) CA1234048A (it)
CH (1) CH663901A5 (it)
CS (1) CS272759B2 (it)
DD (1) DD216384A5 (it)
DE (1) DE3406419A1 (it)
DK (1) DK82784A (it)
ES (1) ES529961A0 (it)
FR (1) FR2541116B1 (it)
GB (1) GB2135190B (it)
HU (1) HU188847B (it)
IT (1) IT1196032B (it)
NL (1) NL8400511A (it)
PL (1) PL246306A1 (it)
PT (1) PT78132B (it)
YU (1) YU33284A (it)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
JPS62162963A (ja) * 1986-01-10 1987-07-18 Sadao Shiosaka 金属コロイド粒子を担体とする低分子物質に対する特異抗体の作成法
GB8601279D0 (en) * 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
US4762710A (en) * 1986-06-16 1988-08-09 The United States Of America As Represented By The Department Of Health And Human Services Novel method of preparing toxoid by oxidation and metal ions
CA1337859C (en) * 1987-04-24 1996-01-02 Masashi Chazono Method for culturing bordetella pertussis, a pertussis toxoid and a pertussis vaccine
US5139776A (en) * 1987-04-24 1992-08-18 The Research Foundation For Microbial Diseases Of Osaka University Method for culturing Bordetella pertussis, a pertussis toxoid and a pertussis vaccine
US5290563A (en) * 1989-07-27 1994-03-01 Laboratoire Des Stallergenes Method for combining a mixture of heterogeneous substances with liposomes
MX170503B (es) * 1990-05-10 1993-08-26 Univ Mexico , "procedimiento para obtener un reactivo antigenico util para determinar indirectamente salmonella typhi.
GB9125695D0 (en) * 1991-12-03 1992-01-29 Mastavac Limited Medical preparations
EP0678035B9 (en) * 1993-01-08 2006-12-13 Csl Limited Vaccine preparations
US6274552B1 (en) 1993-03-18 2001-08-14 Cytimmune Sciences, Inc. Composition and method for delivery of biologically-active factors
US5902565A (en) * 1993-12-24 1999-05-11 Csl Limited Spray dried vaccine preparation comprising aluminium adsorbed immunogens
US20010055581A1 (en) * 1994-03-18 2001-12-27 Lawrence Tamarkin Composition and method for delivery of biologically-active factors
US6407218B1 (en) * 1997-11-10 2002-06-18 Cytimmune Sciences, Inc. Method and compositions for enhancing immune response and for the production of in vitro mabs
US7229841B2 (en) * 2001-04-30 2007-06-12 Cytimmune Sciences, Inc. Colloidal metal compositions and methods
GB2342922B (en) * 1998-10-19 2002-12-24 Jeyes Group Plc Lavatory cleansing block
BRPI0014142B8 (pt) * 1999-08-24 2021-05-25 Abic Biological Laboratories Ltd composição de vacina comprimida estável, e, pacote para vacinação
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
US20060269575A1 (en) * 2000-02-08 2006-11-30 Allergan, Inc. Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
US20030138460A1 (en) * 2000-02-08 2003-07-24 Allergan, Inc Methods of treating animals with botulinum toxin pharmaceutical compositions
US7780967B2 (en) * 2000-02-08 2010-08-24 Allergan, Inc. Reduced toxicity Clostridial toxin pharmaceutical compositions
US8632785B2 (en) * 2000-02-08 2014-01-21 Allergan, Inc. Clostridial toxin pharmaceutical composition containing a gelatin fragment
EP1398038B2 (en) * 2000-02-08 2011-01-26 Allergan, Inc. Botulinum toxin pharmaceutical compositions
US20030118598A1 (en) * 2000-02-08 2003-06-26 Allergan, Inc. Clostridial toxin pharmaceutical compositions
US20020120228A1 (en) * 2000-06-08 2002-08-29 Yuh-Fun Maa Powder compositions
US20040213798A1 (en) * 2000-06-08 2004-10-28 Powderject Vaccines, Inc. Spray-dried alum compositions
CN1438874A (zh) * 2000-06-08 2003-08-27 宝德杰克特疫苗有限公司 粉末组合物
KR100401423B1 (ko) * 2001-01-10 2003-10-17 주식회사 엘지생명과학 혼합 백신의 제조 방법
EP1399131A2 (en) * 2001-06-08 2004-03-24 Powderject Vaccines, Inc. Spray freeze-dried compositions
AU2004311630A1 (en) * 2003-12-02 2005-07-21 Cytimmune Sciences, Inc. Methods and compositions for the production of monoclonal antibodies
EP1715971A4 (en) * 2004-01-28 2010-10-13 Cytimmune Sciences Inc FUNCTIONALIZED COLLOIDAL METAL COMPOSITIONS AND METHODS
JP2009510136A (ja) 2005-10-04 2009-03-12 アルク−アベッロ エイ／エス 固体ワクチン製剤
US20110014118A1 (en) * 2007-09-21 2011-01-20 Lawrence Tamarkin Nanotherapeutic colloidal metal compositions and methods
US20090104114A1 (en) * 2007-09-21 2009-04-23 Cytimmune Sciences, Inc. Nanotherapeutic Colloidal Metal Compositions and Methods
US7960145B2 (en) * 2007-11-08 2011-06-14 Cytimmune Sciences, Inc. Compositions and methods for generating antibodies
GB0822633D0 (en) * 2008-12-11 2009-01-21 Novartis Ag Formulation
GB0916570D0 (en) * 2009-09-21 2009-10-28 Royal Holloway & Bedford New C Method

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2085391A (en) * 1934-01-31 1937-06-29 Sharp & Dohme Inc Lyophilic biologically active substances and process of producing the same
US3097140A (en) * 1958-10-31 1963-07-09 Merck & Co Inc Preparing a mixed polio, pertussis, tetanus, and diphtheria vaccine with benzethonium chloride
GB895073A (en) * 1959-11-23 1962-05-02 Wellcome Found Immunising preparations containing clostridium perfringens toxins and toxoids
US3395219A (en) * 1964-12-11 1968-07-30 Merck & Co Inc Process for production of pertussis antigen
NL6600706A (it) * 1965-02-05 1966-08-08
GB1081796A (en) * 1965-08-13 1967-08-31 Wright Fleming Inst Of Microbi Improvements in or relating to oily adjuvants for water-in-oil emulsions of antigenic materials
US3405218A (en) * 1965-09-22 1968-10-08 Parke Davis & Co Extracting bordetella pertussis antigens with lithium bromide
GB1145320A (en) * 1966-05-20 1969-03-12 Ustav Ser A Ockovacich Latek O Process for the preparation of bacterial cultures for vaccines against pertussis and
GB1152607A (en) * 1967-03-08 1969-05-21 Pfizer Ltd Antigenic Compositions
GB1218277A (en) * 1968-08-20 1971-01-06 Miles Lab Dry water-dispersible aluminium hydroxide gels
US3599150A (en) * 1969-08-01 1971-08-10 Miles Lab Stabilized aluminum hydroxide suspensions
FR2181426B1 (it) * 1972-04-06 1974-12-20 Pasteur Institut
FR2227861B1 (it) * 1973-05-04 1976-07-02 Anvar
DE2355094C3 (de) * 1973-11-03 1979-05-23 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines Tetanus-Impfstoffs
DE2461439C3 (de) * 1974-12-24 1980-03-20 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines schützenden Antigens von Bordetella Pertussis sowie jenes enthaltendes Mittel
JPS5296729A (en) * 1976-02-05 1977-08-13 Shionogi & Co Ltd Mixed vaccin for cyanomycosis
US4273762A (en) * 1979-12-03 1981-06-16 Merck & Co., Inc. Lyophilization process for live viral compositions
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines

Also Published As

Publication number Publication date
CA1234048A (en) 1988-03-15
GB2135190A (en) 1984-08-30
PT78132A (en) 1984-03-01
YU33284A (en) 1987-10-31
FR2541116B1 (fr) 1988-07-15
CH663901A5 (de) 1988-01-29
BE898955A (fr) 1984-08-20
CS122584A2 (en) 1990-06-13
DD216384A5 (de) 1984-12-12
DK82784D0 (da) 1984-02-21
DE3406419A1 (de) 1984-08-23
IT1196032B (it) 1988-11-10
FR2541116A1 (fr) 1984-08-24
ES8506451A1 (es) 1985-07-16
JPS59196821A (ja) 1984-11-08
PL246306A1 (en) 1985-02-27
US4578270A (en) 1986-03-25
PT78132B (en) 1986-05-19
NL8400511A (nl) 1984-09-17
ES529961A0 (es) 1985-07-16
CS272759B2 (en) 1991-02-12
GB8403921D0 (en) 1984-03-21
GB2135190B (en) 1986-10-22
IT8419729A0 (it) 1984-02-21
HU188847B (en) 1986-05-28

Similar Documents

Publication Publication Date Title
DK82784D0 (da) Fremgangsmade til fremstilling af lyofiliserede, adsorberede polyvalente vacciner
DK260682A (da) Fremgangsmaade til fremstilling af partikelformige geler
DK457984A (da) Fremgangsmaade til fremstilling af faste farmaceutiske praeparater med forsinket frigivelse
DK251589D0 (da) Fremgangsmaade til fremstilling af 1,3-dioler
DK22387D0 (da) Fremgangsmaade til fremstilling af ethanol
DK164909C (da) 4-hydroxycumarinforbindelser, fremgangsmaade til fremstilling heraf, rodenticidt praeparat samt fremgangsmaade til udryddelse af gnavere
DK382785D0 (da) Alfa-(o-chlorphenyl)-aminomethylen-beta-formylaminopropionitril, fremgangsmaade til fremstilling af dette samt anvendelse af dette til fremstilling af 2-methyl-4-amino-5-formylaminomethyl-pyrimidin
DK325686A (da) Fremgangsmaade til fremstilling af pulverformet, fritflydende tocoferylsuccinat
DK93684A (da) Fremgangsmaade til adjuvering af oliefri vacciner
DK47684D0 (da) Fremgangsmaade til fremstilling af proteinhydrolysater
DK601489D0 (da) Fremgangsmaade til fremstilling af alkansulfonamider
DK68784D0 (da) Kontinuert fremgangsmade til fremstilling af 5-oxo-2,4-dichlor-4-substituerede pentannitriler
DK287484A (da) Fremgangsmaade til fremstilling af acetaldehyd
DK315789D0 (da) Fremgangsmaade til fremstilling af halogenerede sulfoner
DK481584A (da) Fremgangsmaade til fremstilling af antineoplastisk virkende praeparater
DK586284D0 (da) Quinoloncarboxylsyre-derivater, fremgangsmaade til fremstilling deraf samt anvendelse af saadanne derivater som laegemiddel
DK34888D0 (da) Fremgangsmaade til fremstilling af n,n-(dibenzohexatrienylen)urinstoffer
DK533287A (da) Fremgangsmaade til fremstilling af azetidinoner
DK605384A (da) Fremgangsmaade til fremstilling af azetidinoner
DK184687A (da) Fremgangsmaade til fremstilling af diacetonesorbose
DK108880A (da) Fremgangsmaade til fremstilling af 3!,4!-diepi-4!-o-methyldaunorubicin eller 3!,4!-diepi-4!-o-methyldoxorubicin
DK133784D0 (da) Fremgangsmaade til fremstilling af azinomethylrifamyciner
DK233180A (da) Fremgangsmaade til fremstilling af 8-fluordibenzo (b,f) thiepiner
DK142988A (da) Fremgangsmaade til fremstilling af cycliske terpenoider
DK161513C (da) Fremgangsmaade til fremstilling af n,n-dimethylaminomethylarylforbindelser

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment